MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/23/1760/001  APRETUDE   
EU/1/23/1760/002  APRETUDE   
30 mg 
600 mg 
EU/1/23/1760/003  APRETUDE   
600 mg 
Film-coated tablet  Oral use 
Prolonged-release 
suspension for 
injection 
Prolonged-release 
suspension for 
injection 
Intramuscular use  vial (glass) 
bottle (HDPE) 
Intramuscular use  vial (glass) 
3 ml (200 mg/ml) 
30 tablets  
1 vial  
3 ml (200 mg/ml) 
25 vials  
1/1 
 
 
 
 
